Australie - anglais - Department of Health (Therapeutic Goods Administration)

leica biosystems melbourne pty ltd - ct929 - acquired genetic alteration ivds - for the qualitative detection of; a) her2 (human epidermal growth factor receptor 2) oncoprotein status via immunohistochemistry or b) amplification of her2/neu gene via fluorescence in situ hybridization (fish) in formalin-fixed, paraffin-embedded human breast cancer tissue specimens. as an aid in the assessment of patients for whom herceptin?* (trastuzumab) treatment is being considered

Australie - anglais - Department of Health (Therapeutic Goods Administration)

roche diagnostics australia pty limited - ct929 - acquired genetic alteration ivds - the ventana anti-her2/neu (4b5) rabbit monoclonal primary antibody (ventana her2 (4b5)) is intended for the semi-quantitative detection of her2 antigen in sections of formalin-fixed, paraffin-embedded normal and neoplastic breast and gastric tissue on a ventana automated slide staining device. it is indicated as an aid in the assessment of breast and gastric cancer patients for whom herceptin treatment is considered. the results of this test should be evaluated within the context of the patient?s clinical history and other diagnostic tests evaluated by a qualified pathologist. any staining performed in the end user?s lab should be interpreted within the context of the controls run with the clinical cases at the time of evaluation.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

sysmex australia pty ltd - ct929 - acquired genetic alteration ivds - detection of ck19 mrna in surgically removed regional lymph node in breast cancer (used for an aid to the diagnosis of lymph node metastasis in breast cancer)

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agrobest australia pty ltd - phosphorous (phosphonic) acid present as mono & di potas - liquid - phosphorous (phosphonic) acid present as mono & di potas mineral-phosphorus acid active 400.0 g/l - fungicide - avocado | citrus - well established (see aliases) | citrus - young or small | cucurbit | grape | ornamental | pineapple | subter - collar rot - phytophthora spp. | downy mildew | downy mildew on cucurbit | phytophthora root rot | soil fungi

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

liquid fertiliser pty ltd - phosphorous acid present as mono-di potassium phosphite - liquid - phosphorous acid present as mono-di potassium phosphite mineral-phosphorus-acid active 400.0 g/l - fungicide - avocado | citrus - mature (see label for exception | citrus - young or small | grape | ornamental | pineapple | subterranean clo - collar rot - phytophthora citrophthora | crown top rot | downy mildew on grape | heart rot - phytophthora parasitica | phytophthora root rot | phytophthora root rot - p. nicotianae | root rot - phytophthora cinnamomi | root rot - phytophthora clandestina | crown rot | phytophthora root rot | soil fungi

Israël - anglais - Ministry of Health

novartis israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 100 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist).glivec is also indicated for the treament of : * adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy.* adult patients with relapsed or refractory ph + all as monotherapy.* adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. * adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr (platelet - derived growth factor receptor ) gene re- arrangements. * adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration fo chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative. * adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation.* adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.

Israël - anglais - Ministry of Health

novartis israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 400 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : * adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. * adult patients with relapsed or refractory ph + all as monotherapy. * adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. * adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr (platelet - derived growth factor receptor ) gene re- arrangements. * adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration for chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative. * adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation. * adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.

Irlande - anglais - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - isoleucine; leucine; lysine hydrochloride; methionine; phenylalanine; threonine; tryptophan; valine; arginine; histidine hydrochloride monohydrate; alanine; glycine ph. eur; aspartic acid; glutamic acid; proline; serine; sodium hydroxide; sodium chloride; sodium acetate trihydrate; potassium acetate; magnesium acetate trihydrate; calcium chloride dihydrate; glucose monohydrate; sodium dihydrogen phosphate dihydrate; zinc acetate dihydrate; triglycerides, medium chain; soya bean oil, refined ph. eur.; omega- - emulsion for infusion - solutions for parenteral nutrition; combinations

Irlande - anglais - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - ibuprofen ph. eur. - tablet - 400 milligram(s) - propionic acid derivatives; ibuprofen

Irlande - anglais - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - soya bean oil, refined ph. eur.; medium chain triglycerides; refined olive oil; fish oil, rich in omega-3 acids; isoleucine; leucine; methionine; lysine acetate; phenylalanine; threonine; tryptophan; valine; arginine; histidine; alanine; glycine; proline; serine; tyrosine; taurine; calcium chloride dihydrate; sodium glycerophophate hydrate; magnesium sulphate heptahydrate; potassium chloride; sodium acetate trihydrate; zinc sulphate heptahydrate; glucose monohydrate - emulsion for infusion - unknown - solutions for parenteral nutrition; combinations